InvestorsHub Logo
Followers 20
Posts 2687
Boards Moderated 1
Alias Born 12/03/2020

Re: clambottler post# 149204

Sunday, 02/28/2021 2:10:51 PM

Sunday, February 28, 2021 2:10:51 PM

Post# of 232961
Exactly plus the critical statistical defects of everything that has been published by Cytodyn:
- The HIV studies which all have strong methodological defects + bad stats once these are looked for (no wonder why the HIV BLA has been delayed for years)
- The Leronlimab eIND studies the same (no wonder Cytodyn is delaying now that serious studies, CD10 and CD12, could reveal the truth)
- The cancer sideshow the same

Note these studies are all done by people who have a financial link with Cytodyn. This is what I call sell-side research. Like sell-side research on Wall Street, same rosy glasses and same important factual questions magically sidestepped in the papers. No wonder why smart, educated people avoid answering the key questions in their paper: of course they know perfectly about these questions, they just don't want to answer these! Why killing the golden goose when it gives you golden eggs.

I am happy waiting for the long haulers study which will demonstrate the same qualities.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News